| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |